Q3 EPS Estimate for Sintx Technologies Raised by Analyst

Sintx Technologies, Inc. (NASDAQ:SINT) – Research analysts at Ascendiant Capital Markets boosted their Q3 2026 earnings estimates for Sintx Technologies in a note issued to investors on Wednesday, September 30th. Ascendiant Capital Markets analyst E. Woo now forecasts that the company will post earnings of ($0.33) per share for the quarter, up from their prior estimate of ($0.54). Ascendiant Capital Markets has a “Buy” rating and a $12.50 price objective on the stock. The consensus estimate for Sintx Technologies’ current full-year earnings is ($1.67) per share. Ascendiant Capital Markets also issued estimates for Sintx Technologies’ Q4 2026 earnings at ($0.32) EPS, Q1 2027 earnings at ($0.30) EPS, Q2 2027 earnings at ($0.31) EPS, Q3 2027 earnings at ($0.30) EPS, Q4 2027 earnings at ($0.30) EPS and FY2027 earnings at ($1.21) EPS.

Sintx Technologies (NASDAQ:SINT) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02). Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.46 million.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Friday, July 17th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Sintx Technologies presently has an average rating of “Moderate Buy” and an average price target of $9.50.

Sintx Technologies Stock Performance

NASDAQ SINT opened at $2.18 on Tuesday. Sintx Technologies has a 52 week low of $1.40 and a 52 week high of $4.64. The company has a 50 day moving average price of $1.73 and a 200 day moving average price of $2.03.

Sintx Technologies Company Profile

SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.

The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.